ZIOPHARM ONCOLOGY INC's ticker is and the CUSIP is 98973P951. A total of 4 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $383,000 | +2027.8% | 116,700 | +1456.0% | 0.00% | – |
| Q1 2020 | $18,000 | -96.4% | 7,500 | -92.9% | 0.00% | – |
| Q4 2019 | $499,000 | -86.7% | 105,800 | -87.9% | 0.00% | -100.0% |
| Q3 2019 | $3,739,000 | +8.3% | 873,500 | +45.2% | 0.00% | 0.0% |
| Q2 2019 | $3,452,000 | +1448.0% | 601,400 | +936.9% | 0.00% | – |
| Q1 2019 | $223,000 | – | 58,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 37,200 | $23,436 | 0.00% |
| SIMPLEX TRADING, LLC | 13,700 | $8 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |